Literature DB >> 14855538

Clinical experiences with ACTH and cortisone in ocular diseases.

J M McLEAN, D M GORDON, H KOTEEN.   

Abstract

Entities:  

Keywords:  ACTH; CORTISONE; EYES

Mesh:

Substances:

Year:  1951        PMID: 14855538

Source DB:  PubMed          Journal:  Trans Am Acad Ophthalmol Otolaryngol        ISSN: 0002-7154


× No keyword cloud information.
  12 in total

1.  Central serous retinopathy.

Authors:  G BENNETT
Journal:  Br J Ophthalmol       Date:  1955-10       Impact factor: 4.638

2.  Cortisone in the treatment of syphilitic eye disease.

Authors:  A N ASHWORTH
Journal:  Br J Vener Dis       Date:  1953-03

3.  Present status of corticotropin; ACTH, cortisone, and hydrocortisone in ophthalmology.

Authors:  D M GORDON; J M MCLEAN; H KOTEEN
Journal:  Br J Ophthalmol       Date:  1953-02       Impact factor: 4.638

4.  Macular degeneration treated with cortisone.

Authors:  H E HOBBS
Journal:  Proc R Soc Med       Date:  1953-03

5.  Possible applications of adrenocorticotrophic hormone (ACTH) and cortisone in syphilis.

Authors:  G O HORNE
Journal:  Br J Vener Dis       Date:  1952-09

6.  Retrolental fibroplasia; early development and the effect of ACTH in treatment.

Authors:  C A BROWN; B CORNER
Journal:  Br J Ophthalmol       Date:  1952-06       Impact factor: 4.638

7.  The clinical value of cortisone and ACTH in ocular disease; a preliminary assessment for the Medical Research Council.

Authors:  S DUKE-ELDER
Journal:  Br J Ophthalmol       Date:  1951-11       Impact factor: 4.638

8.  Uses and limitations of ACTH and cortisone in ophthalmology.

Authors:  A C WOODS
Journal:  Br J Ophthalmol       Date:  1952-08       Impact factor: 4.638

9.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

Review 10.  Steroids and the eye--indications and complications.

Authors:  W J Dinning
Journal:  Postgrad Med J       Date:  1976-10       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.